Skip to content

Fully Automatic Electronic Blood Pressure Monitor

by Andon Health Co., Ltd. 17 variants

510(k) K183534

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Abbreviated NumberK183534 Date16 May 2019ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DXN
FDA applicant
Andon Health Co, Ltd.
Device Class
Class II
Regulation
21 CFR Part 870.1130
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

This device is a Fully Automatic Electronic Blood Pressure Monitor (Product Code: DXN), classified as a non-invasive blood pressure measurement system. It is designed to automatically measure and display both systolic and diastolic blood pressure readings without manual inflation of the cuff. The monitor operates electronically, providing accurate and convenient measurements for clinical or home use by trained personnel or individuals.

The monitors are supplied as reusable devices intended for repeated use in clinical or home settings. They comply with FDA 510(k) clearance (K183534) under the Cardiovascular (CV) advisory committee and are classified as Class II under Special Controls. No specific sterility or MRI safety information is provided in the data, and storage conditions are not detailed beyond standard manufacturer guidelines. The device models (KD-753, KD-738BR, KD-733) are explicitly listed as part of the authorized submission.

Other devices from Andon Health Co., Ltd.

See all devices from Andon Health Co., Ltd. →

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Andon KD-753 used for?

    The Andon KD-753 is a fully automatic electronic blood pressure monitor designed to measure and display both systolic and diastolic blood pressure readings automatically. Unlike manual devices, it eliminates the need for manual cuff inflation, providing convenient and accurate measurements for clinical or home use by trained personnel or individuals.

  • How is the Andon Fully Automatic Electronic Blood Pressure Monitor supplied?

    The device is supplied as a reusable system, intended for repeated use in clinical or home settings. This design ensures durability and cost-effectiveness over time, as it does not require single-use components or disposable parts.

  • Are the Andon models KD-753, KD-738BR, and KD-733 interchangeable?

    Yes, these models (KD-753, KD-738BR, and KD-733) are explicitly listed as part of the same FDA-authorized submission (K183534). While they may share core functionality, users should verify specific features, cuff sizes, or software compatibility in the manufacturer’s instructions to ensure proper operation for their intended use.

  • Is sterility a requirement for the Andon Fully Automatic Electronic Blood Pressure Monitor?

    The provided data does not specify any sterility requirements for this device. Since it is classified as reusable and intended for clinical or home use, standard cleaning and disinfection protocols (as outlined by the manufacturer) should be followed to maintain hygiene and prevent cross-contamination.

  • What regulatory pathway does the Andon Fully Automatic Electronic Blood Pressure Monitor follow?

    The device follows the FDA’s 510(k) clearance pathway, specifically under the Cardiovascular (CV) advisory committee. It was granted clearance (K183534) as substantially equivalent to a predicate device, classified under Class II with Special Controls. This pathway ensures compliance with U.S. regulatory standards for non-invasive blood pressure measurement systems.